Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

about

Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.

P2860

Q28070040-BD5BFC24-073D-489D-A452-0D7F1D08FCD9 Q36115240-210B4549-7AE4-4906-9A2C-AED0F13C349D Q55486735-14A994A9-1424-4F62-9028-1A02438087DF

P2860

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

Item

http://www.wikidata.org/entity/Q38508246

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

@en

type

Item

label

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

@en

prefLabel

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

@en

P1476

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients

@en

P2093

Areeba Sadiq

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sclerosis

Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis

Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.

Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial.

Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder.

Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study.

Lower urinary tract symptom prevalence and management among patients with multiple sclerosis

Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.

The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines.

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology

P2888

s11934-015-0519-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11934-015-0519-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin M Brucker

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039397743

http://www.w3.org/2001/XMLSchema#string

P698

26025495

http://www.w3.org/2001/XMLSchema#string

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

about

P2860

P2860

Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698